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Gene regulatory networks (GRNs) regulate critical
events during development. In complex tissues,
such as the mammalian central nervous system
(CNS), networks likely provide the complex regula-
tory interactions needed to direct the specification
of the many CNS cell types. Here, we dissect a GRN
that regulates a binary fate decision between two
siblings in the murine retina, the rod photoreceptor
and bipolar interneuron. The GRN centers on Blimp1,
one of the transcription factors (TFs) that regulates
the rod versus bipolar cell fate decision.We identified
a cis-regulatory module (CRM), B108, that mimics
Blimp1 expression. Deletion of genomic B108 by
CRISPR/Cas9 in vivo using electroporation abolished
the function of Blimp1. Otx2 and RORb were found
to regulate Blimp1 expression via B108, and Blimp1
and Otx2 were shown to form a negative feedback
loop that regulates the level of Otx2, which regulates
the production of the correct ratio of rods and bipolar
cells.
INTRODUCTION
Many studies have been carried out wherein individual genes are
manipulated and their effects on cell types characterized. In
most instances, these are transcription factors or elements of
a signaling pathway (Afelik and Jensen, 2013; Lee and Pfaff,
2001; Nakajima, 2011). The expression patterns ofmany of these
genes, and their effects, are often spread acrossmany cell types.
Nevertheless, they are able to play specific roles in different
times and places. The consensus is that specific outcomes are
due to different contexts in different cells (Kamachi and Kondoh,
2013). Chromatin structure, microRNAs, and other transcripts
and proteins undoubtedly create such contexts. However,
studies that define a particular context are difficult and, for the
most part, have not been carried out. To dissect such complex-
ities, it is useful to have a system by which one can manipulate
gene expression, ideally in vivo. In addition, a system in which
one can readily discover the cis-regulatory sequences requiredDevelopmefor gene regulation is advantageous. The murine retina offers
such a system (Kim et al., 2008a; Matsuda and Cepko, 2004,
2007). We have exploited this system to address a binary fate
decision in the mammalian retina.
The retina is a highly evolved sense organ, which uses photo-
receptors to capture light and create neural signals that are
transmitted to other retinal neurons. Parallel processing of these
visual signals is carried out by more than 60 retinal cell types
to extract selected features from the visual scene (Masland
and Raviola, 2000; Meister, 1996). There are a large number of
inherited diseases of the retina, most due to dysfunction and
loss of photoreceptor cells (Boucherie et al., 2011). An under-
standing of the specification of retinal neurons can greatly inform
the development of therapies to treat such diseases, e.g., the
production of photoreceptor cells from stem cells (Ong and da
Cruz, 2012).
During retinal development, retinal cell types are specified
from a pool of multipotent retinal progenitor cells (RPCs) in a
temporal order (Livesey and Cepko, 2001). RPCs can produce
two very different cell types in a terminal division. One such divi-
sion produces a rod photoreceptor cell and an interneuron, the
bipolar cell (Turner and Cepko, 1987). There have been several
studies that have identified transcription factors (TFs) that
impact these two fates (Brzezinski et al., 2010; Jia et al., 2009;
Katoh et al., 2010; Koike et al., 2007; Ohsawa and Kageyama,
2008; Sato et al., 2007). Many of these genes impact more retinal
cell types than just the rods and bipolar cells. We wished to un-
derstand the gene regulatory network (GRN) operating within the
RPCs and their newly postmitotic progeny at the time when this
rod versus bipolar cell binary decision is beingmade. Binary cell-
fate decisions have been well studied in invertebrates and in
vertebrate hematopoiesis (Graf and Enver, 2009; Jukam and
Desplan, 2010). However, in themammalian central nervous sys-
tem (CNS), including the retina, the TFs that control cell-fate de-
cisions have been mainly studied by gain- and loss-of-function
manipulations of individual TFs. The participation of TFs within
a GRN and the cis-regulatory modules (CRMs) that they utilize
have not been systematically addressed. Here, we have identi-
fied interactions of key TFs that regulate the final ratio of rods
versus bipolar cells within the rod-bipolar GRN, based on the
identification of a CRM for Blimp1, a gene that is important in
this GRN. We also used in vivo electroporation to interrogate
the necessity of this CRM, after first testing CRISPR/Cas9
(Cong et al., 2013; Mali et al., 2013; Sternberg et al., 2014) in antal Cell 30, 513–527, September 8, 2014 ª2014 Elsevier Inc. 513
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Figure 1. Identification of Enhancers for the Blimp1 Gene
(A) TheBlimp1 locus viewed by the ECR Browser Program. Themouse reference genomic sequence is aligned with that of other species. The transcript of mouse
Blimp1 gene is shown on the top. Blue, coding sequences; yellow, untranslated regions; red, conserved regions upstream of Blimp1; light brown, introns.
(legend continued on next page)
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The GRN for Retinal Cell Fate Specificationreporter strain of mice to determine the effectiveness of this
method to create genomic alterations in tissues. We found that
CRISPR/Cas9 created homozygous and heterozygous alter-
ations in >50% of the electroporated retinal cells. This method
was then employed for deletion of the Blimp1 CRM, where it
led to the loss of Blimp1 function. Together, all of these experi-
ments led to the identification of the GRN that regulates the
rod versus the bipolar fate. The GRN regulates the level of
Otx2, a gene that is required for the production of both rods
and bipolar cells, whose level determines whether a cell be-
comes a rod or a bipolar cell.
RESULTS
Identification of Retinal Enhancers of the Blimp1 Gene
Blimp1, a zinc-finger transcription factor (also known as Prdm1),
has been shown to be required for the production of the proper
ratio of rods and bipolar cells, as its loss leads to an increase in
bipolar cells and a reduction in rods (Brzezinski et al., 2010,
2013; Katoh et al., 2010). As the first step in the dissection of
the rod-bipolar GRN, we sought to identify the critical CRMs
that control Blimp1 expression in the retina. DNA fragments up-
stream of the Blimp1 transcription start site (TSS) were tested for
their ability to activate expression of reporter genes in devel-
oping mouse retinas, using electroporation into retinal explants.
An 12 kb mouse genomic fragment (B12kb) was able to drive
expression in retinas, and thus a series of deletions were tested
to determine the minimal sequence for this activity (Figure 1).
A 108 bp fragment (B108) was found to be sufficient to drive re-
porter expression in retinas (Figure 1; Figure S1 available online).
B108 was also necessary for the activity of B12kb, as deletion of
this fragment dramatically reduced EGFP expression driven by
B12kb (Figures 2A–2D).
Expression driven by the B108 enhancer was analyzed for
fidelity of expression by comparing it with that of the native
Blimp1, which is transiently expressed. From postnatal day
0 (P0) to P3, Blimp1 is broadly expressed in many retinal cells.
Later, its expression is downregulated, becoming undetectable
by antibody staining and northern blot assay after P7 (Brzezinski
et al., 2010; Katoh et al., 2010). The expression pattern of EGFP
driven by B108 was examined relative to immunohistochemistry
(IHC) for Blimp1 at different developmental stages. When the
B108 reporter was electroporated into retinas in vivo at P0,
90% of EGFP+ cells were positive for Blimp1 IHC signals by
P3 (Figures 2A–2D). Consistent with endogenous Blimp1 expres-
sion pattern, EGFP expression driven by B108 was downregu-
lated beginning at P7 (Figure S2A). We could detect low EGFP
expression in rods after P7 if anti-GFP antibody was used to
amplify the signal, possibly because of the greater stability of
EGFP proteins/mRNAs relative to Blimp1 and/or missing ele-
ments that are responsible for downregulation of Blimp1 within
B108 (Figure S2B). To investigate one possible element for(B) An 12 kb fragment (B12kb) upstream of the Blimp1 gene and a variety of de
and electroporated intomouse retinas, with assessment of EGFP levels indicated
critical for activity.
(C) A series of truncations of the 1 kb fragment were generated based on seq
plasmid individually and tested for activity, as summarized on the left.
See also Figure S1.
Developmedownregulation, we tested whether the addition of the Blimp1
30 UTR to the B12kb construct would lead to a reduction in
expression (Figure S7A). Indeed, a significant reduction was
seen, in keeping with previous studies of Blimp1 regulation in
other tissues, which showed that microRNAs downregulate
Blimp1 through 30 UTR sites (Nie et al., 2008; West et al., 2009;
Zhang et al., 2011). In addition, as Blimp1 has been shown to
negatively regulate its own expression, we coelectroporated
CAG-Blimp1 with the B12kb reporter plasmid and again
observed evidence of negative regulation (Figure S7B). Overall,
the onset of expression and the cells that activated the B108
enhancer recapitulated the endogenous expression of Blimp1
during early postnatal retina development, and additional ele-
ments within a larger regulatory region of Blimp1 are responsible
for fine-tuning the downregulation.
Blimp1 has been reported to be expressed predominantly
in postmitotic cells in the developing retina (Brzezinski et al.,
2010; Katoh et al., 2010). We thus investigated whether B108
activated EGFP expression in postmitotic cells by using EdU,
a thymidine analog, to mark cells in S phase. EGFP+ cells were
rarely found to be EdU+ 1 hr after EdU administration, demon-
strating that B108 was not active in S phase retinal cells (Fig-
ure S2D). We further addressed whether B108 would be active
in G2 or M phase by an EdU pulse-chase assay. In the postnatal
developing retina, the cell-cycle length of mitotic progenitors is
roughly 30 hr (S phase: 16 hr; G2 phase: 3 hr; M phase: 2 hr;
G1 phase: 8 hr) (Young, 1985b). Following a short pulse of EdU
and a 20 hr chase, the majority of EdU+ cells should be in G1/
G0 phase (Figure S2C). Analysis of cells after a 20 hr chase
showed that most EdU+ cells (in G1/G0 phase) had not turned
on EGFP expression, suggesting that they needed more time
to activate B108 (Figure S2D). These experiments further vali-
date the B108 enhancer, as it predominantly drives expression
in postmitotic cells of the postnatal retina, consistent with the
timing of Blimp1 activation.
Lastly, a recent study used the Blimp1-Cre BAC-transgenic
mouse to trace cells with a Blimp1 expression history. Nearly
all photoreceptors, about 30% of bipolar and amacrine cells,
roughly half of horizontal cells, and very few Mu¨ller glial cells
showed a history of Blimp1 expression (Brzezinski et al.,
2013). We were interested in the fate of the cells that activated
the B108 enhancer. Because B108 activity was downregulated
as the cells matured, we needed to use a history assay to
determine which cell fates were marked by the transiently
active B108 enhancer. To this end, we used B108 to drive
Cre expression. A control construct with no enhancer led to
very few cells with Cre history (Figure 2E). Cells that activated
B108 primarily became rods, with a few becoming amacrine
and Muller glial cells, but almost no bipolar cells (Figures
2E–2K). This demonstrated that B108 preferentially tracked
the postnatal Blimp1-expressing cells that adopted the rod
photoreceptor fate.letion variants were inserted upstream of the EGFP gene in a reporter plasmid
on the left. An1 kb fragment (Chr10: 44464199-44465247; GRCm38/mm10) is
uence conservation. These fragments were cloned into the Stagia3 reporter
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Figure 2. Characterization of the B108 Enhancer in Mouse Retinas
(A) Schematics of reporter plasmids. The B108 and B12kb fragment were used to drive EGFP expression. In B12kbD-EGFP plasmid, B108 was deleted
from B12kb fragment.
(B) The constructs shown in (A) were individually electroporated into P0 retinas in vivo with the CAG-LacZ plasmid as an electroporation efficiency control.
Tissue was examined at P3. For detailed procedures, please see the Protocol.
(C) Electroporated retinas were stained with anti-b-galactosidase (blue, label all electroporated cells), anti-GFP (green), and anti-Blimp1 (red) antibodies.
(legend continued on next page)
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The GRN for Retinal Cell Fate SpecificationThese results demonstrate that the B108 enhancer drives
expression in a manner that substantially mimics the endoge-
nous Blimp1 expression in the developing postnatal mouse
retina, during the period when rod photoreceptors and bipolar
cells are born.
CRISPR/Cas9-Based Genome Engineering
Demonstrates that B108 Is Necessary for Endogenous
Blimp1 Expression
To gain a better understanding of the regulation of the endoge-
nous Blimp1 gene, we investigated whether B108 was required
for endogenous Blimp1 expression. With the recent advance
of the RNA-guided genome engineering technique, using
CRISPR/Cas9, targeted engineering of genomic DNA has the
potential to allow a rapid assessment of CRMs within the
genome (Cong et al., 2013; Mali et al., 2013; Sternberg et al.,
2014). We thus tested whether CRISPR/Cas9 could effectively
allow engineering of the mouse genome in vivo in the retina.
The general efficiency of CRISPR/Cas9 in mouse retinas was
examined using the RosamTmG/mTmG mouse strain, which is a
Cre reporter knockin line that utilizes both GFP and Tdtomato re-
porters (Muzumdar et al., 2007). This line expresses membrane
GFP (mGFP) in tissues following the Cre-mediated excision of
the membrane Tdtomato (mTdtomato) cassette (Figure S3A).
We constructed a CRISPR/Cas9 plasmid CRISPRmTmG to
specifically generate DNA double-stranded breaks near both
LoxP sites, by inserting 20 bp targeting sequences into the
CRISPR/Cas9 vector plasmid (Px330), which expresses both
Cas9 and guide RNAs in one plasmid (for detailed procedures,
please see the Protocol). Upon successful cleavage, the ends
of the cleaved DNA are predicted to ligate to each other via the
nonhomologous end-joining (NHEJ) DNA repair pathway, result-
ing in the deletion of the mTdtomato cassette and the switching
on of the mGFP expression. The CRISPRmTmG plasmid was
introduced into retinas of RosamTmG/mTmG mouse pups in vivo
at P0 by electroporation. After 21 days, in the electroporated
region, a significant number of retinal cells turned on mGFP
expression, suggesting that CRISPRmTmG successfully deleted
themTdtomato cassette from the genome (Figure S3B). Roughly
80% of rods, 30% of bipolar cells, 70% of Muller glial cells, and
40% of amacrine cells, which received the CRISPRmTmG
plasmid, turned on mGFP expression.
Given the relatively high efficiency of CRISPR/Cas9 in the
retina in vivo, we next investigated whether we could delete
the B108 enhancer from the genomic locus. CRISPR/Cas9 plas-
mids were constructed to generate double-strand breaks 50 and
30 to B108 in the mouse genome, and PCR primers were de-(D) The percentage of Blimp1+GFP+LacZ+ retinal cells was calculated over differe
turned on reporter EGFP and expressed Blimp1 protein. GFP+LacZ+: electropo
protein. LacZ+: all electroporated cells. Error bars, SD.
(E–G) Schematics of plasmids are shown on top. CAG-loxP-STOP-loxP-EGFP,
constitutively expressed H2bRFP in all electroporated cells. Vector-Cre, negati
B108-Cre, Cre expression was driven by B108. The indicated combinations of plas
and stained with anti-GFP (green), anti-Chx10 (blue), anti-Pax6 (blue), or anti-So
(H–K) Quantification of the fate-mapping experiment. The percentage of electrop
Electroporated rods, H2bRFP+ cells in the outer nuclear layer. Electroporate
H2bRFP+Pax6+. Electroporated Mu¨ller glial cells (MG): H2bRFP+Sox9+. Vector:
combination in (G). Error bars, SEM. Two-tailed Student’s t test (*p < 0.01; **p <
See also Figure S2.
Developmesigned to detect the deletion (Figure 3A). To assay whether the
CRISPR/Cas9 plasmids could delete B108, retinal cells were
electroporated in vivo with CRISPR/Cas9 plasmids and an
EGFP coelectroporation marker (Figure 3B). Genomic DNA
was prepared from fluorescence-activated cell sorting (FACS)-
sorted EGFP+ retinal cells and was subjected to PCR. A smaller
PCR fragment, the size predicted for the B108 deletion, was
observed only when this locus was targeted (the L band in Fig-
ure 3B). Sequencing of the L band PCR fragments as a popula-
tion revealed that the majority of the cleavage events directed by
the CRISPR/Cas9 plasmids, B51 andB33, were at positions 3 bp
50 to the PAM sequence, as predicted for CRISPR/Cas9 activity
(Figure 3C) (Cong et al., 2013). To further investigate the distribu-
tion and types of sequence changes in the targeted region, both
the H band, which corresponded to the wild-type (WT) size, and
the L band were cloned, and individual clones were sequenced
(Figures 3B, S3C, and S3D). The majority of products in the L
band were as seen in the bulk population sequence analysis,
that is, the same result shown in Figure 3C. In addition, there
were single cleavage events recorded in the products from the
H band, and a few other insertions and deletions were seen in
a minority of the products cloned from the H and L bands (Fig-
ures S3C and S3D). These results demonstrated that CRISPR/
Cas9 could be used to assess the requirement for B108 in regu-
lation of Blimp1 in vivo.
Blimp1 conditional knockout (CKO) mice have been shown to
have an increase in bipolar cells and a decrease in rod photore-
ceptors (Brzezinski et al., 2010; Katoh et al., 2010). If the B108
enhancer is required for Blimp1 expression, then the CRISPR/
Cas9-mediated deletion of B108 should recapitulate the CKO
phenotype. The lack of molecular markers that label cells with
successful CRISPR/Cas9 deletion, and the fact that the loss-of-
function phenotype is apparent only after Blimp1 expression is
downregulated, made it difficult to assess the phenotype of cells
that had lost the B108 enhancer. Thus, we used the Cre recombi-
nase-based fate-mapping strategy and examined whether the
production of bipolar cells was increased upon B108 deletion.
Wewere able to follow cells that took on the bipolar fate following
CRISPR/Cas9 action using a reporter plasmid for bipolar cells.
To report bipolar cell identity, the Cre-sensitive reporter
plasmid Chx10BP-LCL-EGFP was constructed (Figure 3D).
This reporter plasmid not only labels bipolar cells specifically
but it also switches expression of fluorescent reporter genes
following Cre-mediated excision. A previously identified Chx10
enhancer that is only active in bipolar cells was used to drive fluo-
rescent protein expression (Emerson and Cepko, 2011; Kim
et al., 2008a). Without Cre, bipolar cells are labeled with mCherrynt retinal cell populations. Blimp1+GFP+LacZ+: electroporated retinal cells that
rated GFP+ cells. Blimp1+LacZ+: electroporated cells that expressed Blimp1
Cre activity reporter. CAG-H2bRFP, electroporation efficiency control, which
ve control for background signals. CAG-Cre, positive control for Cre activity.
mids were electroporated into P0 retinas in vivo. Retinaswere harvested at P14
x9 (blue) antibodies.
orated retinal cells of each type that turned on the Cre reporter was quantified.
d bipolar cells (BP): H2bRFP+Chx10+. Electroporated amacrine cells (AC):
plasmid combinations in (E). CAG: plasmid combination in (F). B108: plasmid
0.001). nR 3. Scale bar, 10 mm.
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Figure 3. Deletion of B108 from the Genome by CRISPR/Cas9 in Retinal Tissue
(A) Schematics of CRISPR/Cas9 plasmids targeting the B108 genomic region. B51, B53, B31, and B33: CRISPR/Cas9 plasmids. pF and pR: primers for the
amplification of the targeted region.
(B) B51 andB33 or B53 andB31were coelectroporated into P0 retinas ex vivo with the CAG-EGFP plasmid, which labels all the electroporated cells. Retinas were
cultured as explants for 5 days, harvested, and dissociated. Genomic DNA was extracted from FACS-sorted EGFP+ retinal cells and subjected to PCR. L (white
(legend continued on next page)
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The GRN for Retinal Cell Fate Specification(Figure 3D). Following Cre-mediated excision ofmCherry, EGFP
would be expressed. To test this construct as a reporter of B108-
Cre activity, the B108-Cre plasmid was delivered into P0 retinas
in vivo along with the Chx10BP-LCL-EGFP reporter. Consistent
with our previous experiment, most bipolar cells were labeled by
mCherry; i.e., they did not have a history of activating B108-Cre
(Figures 2G, 3F, and 3G). To determine if deletion of the endog-
enous B108 element from the endogenous Blimp1 gene would
result in a phenotype consistent with the Blimp1 CKO pheno-
type, the Blimp1 B108 CRISPR/Cas9 plasmids (B51+B33 or
B53+B31), along with the B108-Cre and Chx10BP-LCL-EGFP
plasmids, were electroporated into P0 retinas in vivo, and the
expression of the Chx10BP-LCL-EGFP reporter was assessed
at P14 (Figure 3E; for detailed procedures, please see the Proto-
col). The B108-Cre plasmid does not encode the PAM sequence
or the CRISPR/Cas9 target sites and so would be unaffected
by the CRISPR/Cas9 activity. In contrast to a no CRISPR/Cas9
control, a significant number of EGFP+ bipolar cells were
observed when the endogenous B108 was targeted (Figures
3F and 3G). This result phenocopies the Blimp1 CKO result,
wherein more bipolar cells are generated in the absence of
Blimp1, demonstrating the necessity of the B108 enhancer for
proper Blimp1 regulation in the retina. This result also demon-
strates that the cell-fate change seen following loss of Blimp1
is a cell-autonomous effect.
Identification of Critical Transcription Factor Binding
Sites in the B108 Enhancer
In order to understand the transcriptional regulation of Blimp1,
the B108 enhancer was subjected to a series of analyses to iden-
tify transcription factor binding sites (TFBSs) and their cognate
TFs. We first examined the B108 sequence for sequence con-
servation and then searched for putative TFBSs within the
conserved sequences. B108 showed high sequence conserva-
tion among several species, ranging from zebrafish to human,
with some stretches of nucleotides showing 100% conservation
(Figures 1 and S4). These highly conserved stretches appeared
in clusters, which further suggested theymight be functional reg-
ulatory regions (Arnone andDavidson, 1997; Berman et al., 2002;
Wasserman and Fickett, 1998). To test for function, selected
clusters were mutated individually, and these mutated reporters
were electroporated into retinas to assess reporter activity. Two
of these mutations significantly decreased enhancer activity
compared with the wild-type B108 (RORm andOtxm; Figure S4).
These two clusters were each deleted, and the deletion con-
structs also showed a loss-of-enhancer activity (DROR and
DOtx2; Figure S4). Analysis of these two sequences for TFBSs
by the rVista program and TRANSFAC algorithms suggestedarrow): a lowermolecular weight band created byCRISPR/Cas9. H: the band pred
plasmids were introduced.
(C) The sequence of the L band from (B). PAM (red) sequences and CRISPR-targ
(D) Schematics of the Chx10BP-LCL-EGFP reporter.
(E) Experimental design to test the necessity of the genomic B108. CRISPR/Cas9
retinas in vivo. Retinas were harvested and examined at P14.
(F) Retina sections were stained with anti-GFP antibody (green) and DAPI (blue).
(G) The percentage of EGFP+ cells over all labeled bipolar cells. Error bars, SEM
procedures, please see the Protocol.
See also Figure S3.
Developmethat these two sites corresponded to the binding sites of RORb
and Otx2/Crx (Loots and Ovcharenko, 2004; Matys et al.,
2006). To test the sufficiency of the RORb and Otx2/Crx binding
sites, they were tested for their ability to drive EGFP in retinas
in the absence of other B108 sequences. These two TFBSs
were able to drive strong EGFP expression in the retina (ROx2;
Figure S4).
RORb and Otx2 Regulate Blimp1 Expression via the
B108 Enhancer
We examined whether RORb and Otx2/Crx were indeed up-
stream regulatory TFs of Blimp1 by addressing whether RORb
and Otx2/Crx were necessary for the activation of B108 and
the endogenousBlimp1 gene.We generated plasmids with short
hairpin RNAs (shRNAs) that could efficiently knock down RORb,
Otx2, Crx, or control LacZ expression (Figure S5). These shRNA
constructs were designed based on microRNA structures that
allowed for the use of PolII promoters, such as the CAG pro-
moter, and were located within the 30 UTR of mCherry, which
allowed for the tracking of shRNA expression via expression of
mCherry (Figure S5A) (Qiu et al., 2008).
When either the RORb-shRNA or Otx2-shRNA plasmids were
introduced into retinas, the activity of the B108-EGFP reporter
was dramatically decreased compared with controls within
24 hr (Figures 4A and 4B). In contrast, knockdown of Crx did
not affect the activity of B108. These results suggested that
RORb and Otx2 were required for the activation of B108. To
further investigate the requirement of Otx2, an Otx2Flox/Flox con-
ditional mouse strain was used. Electroporation of this strain with
B108-EGFP reporter and Cre showed a significant reduction in
the activity of B108 (Figure 4C).
To explore whether RORb and Otx2 could directly bind
to B108, we performed electrophoretic mobility shift assay
(EMSA) (Figures 4D and 4E). The fragments within B108 that
contained RORb or Otx2 binding sites were used as DNA
probes. Strong electrophoretic mobility bands were detected
when the wild-type RORb probe was mixed with RORb-
enriched nuclear extracts from 293T cells or wild-type P3 retina
nuclear extracts. When RORb antibody was incubated with
EMSA probes and retina nuclear extracts, the primary EMSA
band disappeared, suggesting that the RORb antibody pre-
vented the binding of RORb proteins to labeled DNA probes.
Furthermore, when the RORb binding site was mutated in the
EMSA DNA probe, no shifted band was detected, demon-
strating the specificity of the binding (Figures 4D and 4E).
Similar results were observed for Otx2, demonstrating that
the regulation of B108 is likely through direct binding of Otx2
and RORb.icted to be the size of aWT or once-cut PCRproduct. Control: noCRISPR/Cas9
eting sites (purple and blue) are highlighted.
plasmids, B108-Cre, and Chx10BP-LCL-EGFP were coelectroporated into P0
. Two-tailed Student’s t test (*p < 0.015). n = 3. Scale bar, 10 mm. For detailed
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Figure 4. RORb and Otx2 Regulate B108
(A) Knockdown of RORb and Otx2 reduced B108 activity. Plasmids that contained different shRNA cassettes were electroporated into P0 retinas ex vivo with
B108-EGFP (2:1 ratio) and the electroporation efficiency control CAG-mCherry. Two different shRNA constructs were used for knocking down RORb or Otx2.
Retinas were cultured as explants for 24 hr and examined. Scale bar, 1 mm.
(B) Quantification of B108 activity. The ratio of total EGFP intensity over mCherry intensity was calculated (Fiji software) and normalized to LacZ-shRNA controls.
Error bars, SEM. Two-tailed Student’s t test (*p < 0.01). nR 4.
(C) The experimental design to test whether Otx2 is required for the activation of B108. Indicated combinations of plasmids were electroporated into P0
Otx2Flox/Flox retinas ex vivo. Retinas were cultured as explants for 24 hr and examined. Scale bars, 500 mm.
(D and E) EMSA. Probe sequences are shown. CAG-LacZ, CAG-Otx2, or CAG-RORb lysates: nuclear extracts of 293T cells that were transfected with CAG-LacZ,
CAG-Otx2, or CAG-RORb plasmid. P3 retina lysate: nuclear extracts of P3mouse retinas. Anti-GFP antibody was used as a negative control. Anti-RORb and anti-
Otx2 antibodies were included as indicated.
See also Figures S4 and S5.
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Figure 5. RORb and Otx2 Regulate Endoge-
nous Blimp1 Expression
(A) Representative images of retinal cells detected
by single-molecule FISH. The RORb-shRNA1or
LacZ-shRNA cassette was placed 30 of an EGFP
gene driven by the CAG promoter. Each plasmid
was electroporated into P0 retinas ex vivo. Retinas
were cultured for 24 hr before dissociation. Cy3-
labeled RORb probes and Cy5-labeled Blimp1
probes were coapplied to detect the expression
levels of RORb and Blimp1. Individual EGFP+
retinal cells that expressed the indicated shRNA
are circled. DAPI marks the nuclei. Scale bar,
10 mm.
(B) Quantification of RORb mRNA levels. LacZ-
shRNA (blue): EGFP+ cells treated with control
LacZ-shRNA plasmids. RORb-shRNA (green):
EGFP+ cells treated with RORb-shRNA1 plasmids.
(C) Quantification of Blimp1 mRNA levels.
(D) Representative images of retinal cells. Otx2-
shRNA1: the Otx2-shRNA1 cassette was placed 30
of an EGFP gene driven by the CAG promoter.
Experiments were performed as described in (A).
Cy3-labeled Otx2 probes and Cy5-labeled Blimp1
probes were coapplied. Scale bar, 10 mm.
(E) Quantification of Otx2 mRNA levels. LacZ-
shRNA (blue): EGFP+ cells treated with control
LacZ-shRNA plasmids. Otx2-shRNA (red): EGFP+
cells treated with Otx2-shRNA1 plasmids.
(F) Quantification of Blimp1 mRNA levels. In (B),
(C), (E), or (F), the x axis represents the number of
dots in each EGFP+ cell, and the y axis represents
the percentage of cells that have the indicated
number of dots. Error bars, SEM. Two-tailed Stu-
dent’s t test (*p < 0.05; **p < 0.01, ***p < 0.001). n =
4 (For each n, more than 200 EGFP+ cells were
counted).
See also Figure S5.
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The GRN for Retinal Cell Fate SpecificationWe further examined whether RORb or Otx2 were required for
the activation of the endogenous Blimp1 gene. As loss of func-
tion of eitherOtx2 or RORb leads to changes in retinal cell types,
we wished to assay whether reduction in the expression of these
TFs would affect Blimp1 expression, without the confound of
changes in retinal cell types. In addition, as electroporation
does not target a large number of cells, and there is a great
deal of heterogeneity in the population of cells that are electropo-
rated, we preferred a method that could be applied to individualDevelopmental Cell 30, 513–527, Scells to measure mRNA levels. To this
end, we used single-molecule fluorescent
in situ hybridization (FISH) (Raj and van
Oudenaarden, 2009). This technique
uses numerous DNA probes (each probe
is 20 bp long and conjugated directly
with fluorophores) to detect a single
mRNA molecule in situ. The hybridized
probes produce a single fluorescent dot
on a single mRNA molecule (Figures 5A
and 5D). Quantification of the number of
dots per cell provides a measure of the
relative mRNA levels for the target gene.
We utilized this technique to detectBlimp1 mRNA levels after shRNA knockdown of RORb or Otx2.
Otx2-shRNA, RORb-shRNA, or LacZ-shRNA were placed 30 to
the EGFP gene and only EGFP+ retinal cells were quantified.
Single-molecule FISH probes for RORb mRNA, Otx2 mRNA, or
Blimp1 mRNA levels were utilized (Figure 5). Twenty-four hours
after shRNA plasmids were electroporated into retinas, when
many retinal cells would still be in the same cell cycle (retinal
cell-cycle length:30 hr), FISHwas performed for all three genes
in individual EGFP+ retinal cells.eptember 8, 2014 ª2014 Elsevier Inc. 521
B108-Cre2
Chx10BP-LCL-EGFP
B108-Otx2-Cre
Chx10BP-LCL-EGFP
B108 IRES Cre B108 IRES CreOtx2
CAG-Cre
Chx10BP-LCL-EGFP
 CreCAG
B
CAG-LacZ
Chx10BP-LCL-EGFP
Chx10BP  mCherry EGFP
 LacZCAG
A C D
E F
Chx10BP  mCherry EGFP Chx10BP  mCherry EGFP Chx10BP  mCherry
EGFP
CAG
-Lac
Z
CAG
-Cre
B108
-Cre2
B108
-Otx2
-Cre
1.2
1
0.8
0.4
0.6
0.2
0
**
pLIA
IRESLTR AP LTR
IRESOtx2
pLIA-Otx2
LTR AP LTR
G
0.8
0
0.2
0.9
0.7
0.1
**
*
1
EG
FP
m
Ch
er
ry
  &
EG
FP
+
+
+
ACRod BP MG
LacZ-shRNA
Otx2-shRNA1
0.8
0.9
0.7
0.6
0.2
0.1
0
**
**
Th
e 
pe
rc
en
ta
ge
 o
f E
G
FP
 
 
ce
lls
 
Th
e 
pe
rc
en
ta
ge
 o
fA
P 
 
ce
lls
+
+
EGFPCAG polyA
EGFP
CAG polyA
ACRod BP MG
pLIA
pLIA-Otx2
LacZ-shRNA
Otx2-shRNA
Figure 6. Dosage of Otx2 Controls the Rod:Bipolar Ratio
(A–D) Schematics of plasmid combinations are shown on top of each panel. Different plasmid combinations were electroporated into P0 retinas in vivo. Retinas
were harvested at P21. Representative images of retina sections are shown for each condition. Red, mCherry. Green, EGFP. Scale bar, 20 mm.
(E) Quantification of the phenotype. The ratios of EGFP+ cells over all labeled bipolar cells were calculated. Error bars, SEM. Two-tailed Student’s t test
(**p < 0.01). n = 3.
(legend continued on next page)
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The GRN for Retinal Cell Fate SpecificationIn the presence of RORb-shRNA, significantly fewer retinal
cells had a high number of RORb signals compared with the
LacZ-shRNA control, demonstrating that the RORb-shRNA
could successfully knock down endogenous RORb levels within
24 hr (Figures 5A and 5B). More importantly, significantly fewer
retinal cells had a high number of Blimp1 signals when RORb
expression was targeted (Figures 5A and 5C). Similar experi-
ments were performed with the Otx2-shRNA. Compared with
controls, significantly fewer retinal cells contained a high number
of Otx2 signals and Blimp1 signals when the Otx2-shRNA was
introduced (Figures 5D–5F). These data demonstrate that
RORb and Otx2 are positive regulators of endogenous Blimp1
expression.
Blimp1 and Otx2 Form a Negative Feedback Loop to
Ensure Proper Rod Photoreceptor Formation
When examining the relationship between Otx2 and Blimp1, we
discovered two Blimp1 binding sites (AGNGAAAG) in a 50 region
of a 600 bp Otx2-enhancer element, ECR2, that we previously
showed to be active in developing photoreceptors (Figure S6A)
(Emerson and Cepko, 2011; Katoh et al., 2010). Given that
Blimp1 predominantly functions as a transcriptional repressor
(John and Garrett-Sinha, 2009), we investigated whether Blimp1
could repress the activity of the Otx2ECR2 enhancer. Electro-
poration of the Otx2ECR2 reporter and a Blimp1 expression
plasmid revealed that the activity of ECR2 was significantly
inhibited by Blimp1 overexpression (Figures S6B and S6C).
Disruption of one of the Blimp1 binding sites released the repres-
sion of Blimp1 on ECR2 (Figures S6C and S6D). EMSA further
showed that Blimp1 could directly bind to the Otx2ECR2
enhancer (Figure S6E). These data demonstrated that Blimp1
and Otx2 can form a negative-feedback loop, which might be
required for the genesis of the proper ratio of rod and bipolar
cells at postnatal stages.
In mature retinas, rod photoreceptors express low levels of
Otx2, whereas bipolar cells express high levels of Otx2 (Fossat
et al., 2007). In addition, the majority of Blimp1+ cells in the
postnatal retina develop into rod photoreceptors (Figures 2G
and 2H) (Brzezinski et al., 2013). These two observations, and
that of Blimp1-mediated repression of Otx2 described above,
suggested that the expression level of Otx2 might be repressed
by Blimp1 and that the level of Otx2 might play a role in the spec-
ification of these two cell types. To test this hypothesis, B108
was used to drive constant high levels of Otx2 expression in
Blimp1-expressing cells, whose fates were then traced.
As used previously in the experiment described in Figure 3, the
Cre-sensitive bipolar reporter plasmid, Chx10BP-LCL-EGFP,
was used to report bipolar cells (Figure 3D). When Cre-express-
ing cells become bipolar cells, they turn on EGFP expression,
whereas bipolar cells with no history of Cre are marked by(F) Knockdown ofOtx2 increases the number of rods and reduces the number of b
(LacZ-shRNA or Otx2-shRNA1 was placed in the 30 UTR of the EGFP gene) wa
distribution of EGFP+ cells among different retinal cell types was examined. Lac
Mu¨ller glial cells. n = 3.
(G) Retroviral mediated overexpression of Otx2. Schematics of retroviral constru
pLIA-Otx2 retroviruses (titer: 107) were injected into P0 retinas in vivo. Tissue was
that were rod, bipolar (BP), amacrine (AC), or Mu¨ller glial cells (MG) was calculat
See also Figure S6.
DevelopmemCherry (Figures 3F, 6A, and 6B). In controls, B108 was used
to drive only Cre expression. Consistent with our previous obser-
vation, very few EGFP+ bipolar cells were observed, demon-
strating that cells that activated B108-Cre do not usually adopt
bipolar cell fates (Figures 2G–2K, 3F, and 6C). To drive sustained
ectopic Otx2 expression only in Blimp1+ cells, the B108-Otx2-
IRES-Cre plasmid was constructed, to express Otx2 and Cre
at the same time under the control of B108. Cre could delete
the mCherry cassette within the Chx10BP-LCL-EGFP reporter,
leading to EGFP+ bipolar cells. Following introduction of B108-
Otx2-IRES-Cre along with the bipolar Chx10BP-LCL-EGFP
reporter in vivo into P0 retinas, a significant number of EGFP+
bipolar cells were observed at P14 (Figures 6D and 6E). This
result illustrated that high levels of Otx2 significantly increased
the probability that Blimp1+ cells, which normally adopt the rod
fate, now adopt the bipolar cell fate. To further investigate the
Otx2 dose-sensitivity for the rod versus bipolar fate decision,
Otx2 levels were reduced by shRNA in vivo. This led to the forma-
tion of more rods and fewer bipolar cells (Figure 6F). In contrast,
when retroviruses that expressed Otx2 and a marker gene, hu-
man placental alkaline phosphatase (PLAP), were used to infect
retinas at P0 in vivo, the number of bipolar cells was significantly
increased compared with controls (Figure 6G). A retrovirus
construct designed to overexpress Otx2 was previously used
for a similar experiment in the retina, with the result that bipolar
cells were reduced (Nishida et al., 2003). We obtained this retro-
viral construct but were unable to repeat Nishida et al.’s result
with their retrovirus construct.
DISCUSSION
This study aimed to understand the GRN that regulates one of
the binary cell-fate specification events in the postnatal retina.
We focused specifically on the decision to become a rod or a bi-
polar cell within a particular time window, P0–P3, during which
this decision is being made in siblings of a terminal division
(Turner and Cepko, 1987). The study was initially focused on
Blimp1, a node in the rod-bipolar GRN. Identification of a small
element, B108, allowed for the discovery of the regulators of
this gene and provided a starting point for the interrelationships
among other elements in this GRN.
The model shown in Figure 7 summarizes our current under-
standing of the rod-bipolar GRN. At postnatal stages, RORb and
Otx2 initiate Blimp1 expression in RPCs that are about to pro-
duce postmitotic daughter cells. As the level of Blimp1 rises,
there is direct negative feedback on Otx2, and Blimp1 nega-
tively regulates its own expression (Figure S7B), as has been
shown in other systems (Magnu´sdo´ttir et al., 2007; Smith
et al., 2007). Cells that experience the drop in Otx2 levels enter
into the rod pathway. An additional arm of the GRN ensures thatipolar cells. The CAG-EGFP-LacZ-shRNA or CAG-EGFP-Otx2-shRNA plasmid
s electroporated into P0 retinas in vivo. Retinas were harvested at P14. The
Z-shRNA: control shRNA plasmid. BP, bipolar cells. AC, amacrine cells. MG,
cts are shown on top. AP, human placental alkaline phosphate (PLAP). pLIA or
harvested and processed for AP detection at P21. The percentage of AP+ cells
ed. Error bars, SEM. Two-tailed Student’s t test (*p < 0.05; **p < 0.01). nR 3.
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Figure 7. Model of the GRN that Regulates Rod and Bipolar Cell Fate
Specification
Otx2 and RORb upregulate Blimp1 expression in newly postmitotic cells
produced by postnatal RPCs. As its level increases, Blimp1 represses the
expression ofOtx2, Chx10, and Blimp1. As a result, retinal cells with low levels
of Otx2 adopt the rod fate. An additional regulator in this GRN is Notch, which
is transcribed in the newly postmitotic cells and inhibits Blimp1. As a result,
these retinal cells obtain high levels of Otx2 and Chx10 and adopt bipolar cell
fate. Otx2might also be a critical positive regulator ofChx10 in bipolar cells via
a distal enhancer, the Chx10 2.5 kb enhancer (Kim et al., 2008a). CRMs/en-
hancers of the GRN are highlighted bars within each gene’s horizontal repre-
sentation. See also Figure S7.
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The GRN for Retinal Cell Fate Specificationthe cells with a high Blimp1 level do not enter into the bipolar
pathway. Previous studies showed that Blimp1 also represses
Chx10, a TF that is essential for bipolar cell genesis (Burmeister
et al., 1996; Katoh et al., 2010). As a result of these repressive
activities of Blimp1, the expression levels of Otx2 and Chx10
are reduced, which favors the rod fate. Additional support for
this model comes from misexpression of Otx2, which results
in overproduction of bipolar cells, likely at the expense of rod
photoreceptors (Figure 6G), and previous work showed the
same result when Chx10 was overexpressed (Livne-Bar et al.,
2006). Similarly, reduction of Blimp1 expression leads to over-
production of bipolar cells (Brzezinski et al., 2010; Katoh
et al., 2010), most likely through the resulting upregulation of
Chx10 and Otx2. In cells that will adopt the bipolar fate, it is
possible that Blimp1 expression is also initiated by RORb and
Otx2, as these two TFs are expressed in bipolar cells (Chow
et al., 1998; Fossat et al., 2007). However, as Blimp1 is not
expressed at detectable levels in bipolar cells, it may not be
activated in these cells, or it is quickly repressed following acti-524 Developmental Cell 30, 513–527, September 8, 2014 ª2014 Elsevation, by as yet undefined repressive effects in bipolar cells.
An additional element of this GRN involves Notch1. We and
others previously found that Notch1 inhibits photoreceptor
formation and is required for bipolar formation (Jadhav et al.,
2006; Mizeracka et al., 2013a; Yaron et al., 2006). Analysis of
mRNA levels in single cells from which Notch1 was deleted
showed a strong upregulation of Blimp1 (Mizeracka et al.,
2013b). Constitutive activation of the Notch signaling pathway
significantly suppressed endogenous Blimp1 expression in
the retina (Figure S7C). These results suggest that the Notch
signaling pathway, at least in part, promotes bipolar formation
and inhibits rod formation via repression of Blimp1. Further
studies on the relationships among bHLH genes downstream
of Notch, as well as of the Notch-regulated TFs, such as
Hes1, Ids, and Blimp1, will help elucidate the complete GRN
that governs the rod versus bipolar cell fate specifications
(Bramblett et al., 2004; Cherry et al., 2011; Mizeracka et al.,
2013b; Morrow et al., 1999; Ohsawa and Kageyama, 2008).
One other regulatory mechanism that controls the level of
Blimp1 is microRNA regulation via the 30 UTR. Previous work
in other tissues showed that the microRNAs, Let7a, miR9, and
miR125b, are relevant microRNAs for this negative regulation
(Nie et al., 2008; West et al., 2009; Zhang et al., 2011). Interest-
ingly, these same microRNAs are present in the retina and likely
play a role in the temporal progression of retinal cell-fate spec-
ification (La Torre et al., 2013), perhaps in part through regula-
tion of Blimp1.
The importance of TF dosage in cell-fate decisions has been
demonstrated in several cases (Sigvardsson, 2012; Struhl et al.,
1992; Taranova et al., 2006). For example, the dosage of PU.1
regulates the B lymphocyte versus macrophage cell fates
in the hematopoietic system (DeKoter and Singh, 2000), and
Ngn3 dictates endocrine differentiation in a dosage-dependent
manner (Wang et al., 2010). However, the mechanisms that
regulate the levels of these TFs have not been well defined.
Here, we show that the level of Otx2 is important for regulating
the rod versus bipolar fates. A low level of Otx2 promotes the
rod fate, whereas a high level of Otx2 induces the bipolar cell
fate, and the level of Otx2 is regulated by Blimp1 in a nega-
tive-feedback loop. These findings have several implications.
First, the rod and bipolar fate decision is not fixed until after
the terminal mitosis, as Blimp1 protein expression is largely
undetected until cell-cycle exit. Consistent with this, previous
studies showed that newly postmitotic cells relied upon new
transcription and translation of the Notch1 gene in order to
take on a nonrod fate (Mizeracka et al., 2013a). The data re-
ported here show that at least a subset of newly postmitotic
cells is sensitive to the levels of Otx2 for their fate decisions.
Second, it has been suggested that Otx2 might be a critical pos-
itive regulator of Chx10 in bipolar cells via a distal enhancer (Kim
et al., 2008a). Thus, high Otx2 levels may promote bipolar cell
formation via the activation of Chx10 (Figure 7). This may
provide an explanation for the lag in bipolar cell differentiation
relative to bipolar cell birthdays. Classical [3H]-thymidine birth-
dating studies showed that some retinal cells born as early as
P0 take on the bipolar fate, with the peak of bipolar birthdays
at P4–P5 (Young, 1985a). However, bipolar cell markers do
not start to appear until P6 (Kim et al., 2008b). This lag may
be due, at least in part, to the time that is required for thevier Inc.
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The GRN for Retinal Cell Fate Specificationinteractions among Otx2, Chx10, and other TFs to occur in the
rod-bipolar GRN to fix the bipolar fate.
Expression profiling studies demonstrated that there is a
great amount of molecular heterogeneity among RPCs (Tri-
marchi et al., 2008). Early clonal lineage analyses showed that
RPCs at the same developmental stage could give rise to
various clonal compositions (Turner and Cepko, 1987). More
recently, lineage studies that examined the clonal progeny of
specific RPCs showed that there are distinctive types of
RPCs, which are biased to produce different types of retinal
cells. Olig2, a bHLH gene, was found to be expressed in the
RPCs that do not make bipolar cells and rods (Hafler et al.,
2012). It will thus be of interest to determine whether Blimp1,
Otx2, and Chx10 regulation might occur differently in Olig2+
and Olig2 RPCs.
In addition to the findings regarding the rod and bipolar GRN,
we report the use of two techniques. Single-molecule RNA FISH
was shown to be able to detect gene expression levels in indi-
vidual cells in a sensitive and quantitative manner. Because
the levels of TFs can be important for developmental events,
the quantitative nature of single-molecule RNA FISH makes it
a valuable method for evaluating transcript levels. In addition,
we showed that CRISPR/Cas9 could successfully delete tar-
geted regions of the genome following electroporation in vivo.
Deletion at the Rosa locus was very efficient, with the rates vary-
ing somewhat with the cell type. It is not clear if the lower rate
seen, e.g., in bipolar cells relative to rods, might be due to the
relatively lower expression of CRISPR/Cas9 in bipolar cells, as
we have noted lower levels of expression in bipolar cells from
the CAG promoter. Chromatin structure might be another factor
that varies among cell types. Enhancer regions, often associ-
ated with low nucleosome occupancy, may make these regions
relatively sensitive to CRISPR/Cas9 engineering (Buecker and
Wysocka, 2012), an asset when studying the role of such
sequences.
Overall, we explored the GRN operating within late RPCs and
their newly postmitotic progeny at the time when rod and bipolar
cell fate decisions are being made, and we identified how TFs
inputs are integrated via CRMs to control the binary cell-fate
specification event. As more and more TFs and CRMs are
analyzed in the context of GRNs, it should be possible to
assemble relatively complete GRNs and study their precise
and complex regulation by establishing computational models.
EXPERIMENTAL PROCEDURES
Animals
Wild-type neonatal mice were obtained from timed pregnant CD1 mice
(Charles River Laboratories). Otx2flox/flox mice were obtained from S. Aizawa
(RIKEN Center for Departmental Biology). RosamTmG/mTmG mice were pur-
chased from The Jackson Laboratory (stock number 007576). All animal
studies were approved by the Institutional Animal Care and Use Committee
at Harvard University.
Plasmids
The CAG-EGFP, CAG-LNL-EGFP, CAG-Cre, CAG-mCherry, and CAG-LacZ
plasmids were from Matsuda and Cepko (Matsuda and Cepko, 2007). The
CAG-H2bRFP was a gift from Dr. S. Tajbakhsh. The Stagia3 vector was ob-
tained from Emerson and Cepko (Billings et al., 2010; Emerson and Cepko,
2011). See the Supplemental Experimental Procedures and Protocol for
details about the construction of all other plasmids.DevelopmeIn Vivo and Ex Vivo Plasmid Electroporation
Ex vivo and in vivo retina electroporation was carried out as described (Cherry
et al., 2011; Matsuda and Cepko, 2007). All ex vivo and in vivo electroporation
experiments were repeated with at least three biological replicates. Plasmids
were mixed in equal mass ratios and electroporated at a concentration of
500 ng/ml to 1 mg/ml per plasmid. For additional details, see the Protocol.
Histology and Immunohistochemistry
Dissected mouse retinas were prepared as previously described (Cherry et al.,
2011). A Leica CM3050S cryostat (Leica Microsystems) was used to prepare
20 mm cryosections. See the Supplemental Experimental Procedures for
detailed antibody sources and dilutions. EdU detection was performed with
a Click-iT EdU Alexa Fluor 594 imaging kit (C10339; Invitrogen).
Dissociation of Retina Tissues and Single-Molecule FISH
Retinal tissuesweredissociated asdescribedpreviously (Trimarchi et al., 2008).
Dissociated retinal cells were left on poly-D-lysine (0.1mg/ml; Millipore) treated
slides for 1 hr at 37C and fixed on slides in 4% PFA (DEPC [pH 7.4]) for 15 min
at room temperature. Single-molecule FISH probes were designed and
ordered from Biosearch Technologies, and their protocol was followed. Imme-
diately after single-molecule FISH, slides were imaged by Nikon Ti Inverted
FluorescenceMicroscopewithPerfect Focus (Nikon ImagingCenter at theHar-
vardMedical School). Imageswere then analyzed by Imaris software (Bitplane).
EMSA
EMSA were performed as described previously (Kim et al., 2008a). Roughly
1 3 106 293T cells were transfected with 1 mg of CAG-LacZ, CAG-Otx2, or
CAG-RORb plasmid. Nuclear extracts were prepared from these cells or P3
wild-type mouse retinas using NE-PER nuclear and cytoplasmic extraction
reagent kit (Pierce). Complementary oligonucleotides (Figure 4D) were
ordered, annealed, and labeled by a DNA 30 End Biotinylation Kit (Pierce).
Chemiluminescent Nucleic Acid Detection Module (Pierce) was used to detect
biotin-labeled probes after EMSA.
Image Analysis
All images of retinal sections were acquired by the Zeiss LSM780 inverted
confocal microscope. Retina explants were imaged by Nikon Eclipse E1000
microscope. 293T cells were imaged by Leica DMI3000B inverted micro-
scope. Images in Figures 2, 3F, and 6 were maximum projections of 5 mm tis-
sues and were quantified by the Imaris software (Bitplane). Images in Figure 4
were quantified by calculating total fluorescent intensities of EGFP or mCherry
via Fiji software.
Statistical Methods
A two-tailed Student’s t test was used to compare differences between control
and experimental values.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and Protocol and can be found with this article online at
http://dx.doi.org/10.1016/j.devcel.2014.07.018.
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